Tua Tagovailoa’s Injury and Why We Need a More Objective Assessment of Head Injuries Now
BETHESDA, MD (October 3, 2022) – The events of the past week have led to significant concern and conversation about Tua Tagovailoa’s health and recovery and have highlighted the need for changes to the NFL’s concussion protocols. When a player hits his head and is visibly shaken and potentially even collapses, this is a good indication that there is a disruption to brain function. However, misinterpretation of subjective evaluations and self-reporting of symptoms can and do lead to inaccurate conclusions.
Incorporating objective evidence into the evaluation of head injury could greatly improve clinical diagnosis, return to play decision-making and ultimately, outcomes. BrainScope’s handheld device provides FDA cleared indications for both the likelihood of concussion and brain bleed at the same time, without radiation and in minutes. The highly validated assessment results provide physicians with objective information that aids in making an informed and accurate diagnosis.
With millions of head injuries in the U.S. each year, it is time to integrate objective biomarkers of injury into clinical diagnosis.
BrainScope is the only FDA cleared non-invasive medical device that objectively assesses head injured patients for both brain bleeds & concussions at point of care.Demonstrated potential to reduce head CT in the ED by 30%-60%
Demonstrated 99% accuracy in identifying the likelihood of the smallest detectable level of blood (>1 mL).
Determine concussion status at same time with same setup and recording.
FDA cleared AI/machine learning derived advanced pattern recognition algorithms are used to determine the likelihood of structural and functional brain injury with high independently validated accuracy.
Click here for a complete list of indications